Literature DB >> 2066109

The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy.

X L Zhang1, M A Rafi, G DeGala, D A Wenger.   

Abstract

Metachromatic leukodystrophy is a severe autosomal recessive disorder caused by accumulation of sulfatide resulting from deficient lysosomal degradation. While most patients have mutations in the lysosomal enzyme arylsulfatase A, some patients have mutations in a required heat stable sphingolipid activator protein, we call SAP-1. One patient with SAP-1 deficiency was previously demonstrated to have a 33-nucleotide insertion in her mRNA. This resulted in the production of mature SAP-1 with 11 extra amino acids, which was unstable during intracellular processing. In this manuscript we demonstrate that the 33 nucleotides are present near the middle of a 4-kb intron, and that a single base change, c to a, in the second position preceding the 33-nucleotide insertion, coupled with the presence of a string of pyrimidines immediately upstream from this change, creates a new 3' splice junction. The presence of a string of pyrimidines within the 33-nucleotide insertion, which has three cag trinucleotides near the 3' end, leads to alternative splicing in normal people as found in this laboratory and by others. The insertion region is followed by a gt dinucleotide that is spliced to a typical 3' consensus sequence. The single nucleotide change, c to a, was confirmed by identifying normal and mutant sequence in the consanguineous parents and a sister, previously identified as a carrier of this disorder.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066109     DOI: 10.1007/BF00204185

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  23 in total

1.  Nucleotide sequence of cloned cDNA for human sphingolipid activator protein 1 precursor.

Authors:  N N Dewji; D A Wenger; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Assignment of the gene for human sphingolipid activator protein-2 (SAP-2) to chromosome 10.

Authors:  S Fujibayashi; F T Kao; C Jones; H Morse; M Law; D A Wenger
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

3.  Saposin A: second cerebrosidase activator protein.

Authors:  S Morimoto; B M Martin; Y Yamamoto; K A Kretz; J S O'Brien; Y Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro.

Authors:  M W Ho; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

5.  Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant.

Authors:  H Christomanou; A Aignesberger; R P Linke
Journal:  Biol Chem Hoppe Seyler       Date:  1986-09

6.  Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus.

Authors:  J S O'Brien; K A Kretz; N Dewji; D A Wenger; F Esch; A L Fluharty
Journal:  Science       Date:  1988-08-26       Impact factor: 47.728

7.  Molecular cloning of a human co-beta-glucosidase cDNA: evidence that four sphingolipid hydrolase activator proteins are encoded by single genes in humans and rats.

Authors:  E G Rorman; G A Grabowski
Journal:  Genomics       Date:  1989-10       Impact factor: 5.736

8.  A variant form of metachromatic leukodystrophy without arylsulfatase deficiency.

Authors:  A F Hahn; B A Gordon; G G Hinton; J J Gilbert
Journal:  Ann Neurol       Date:  1982-07       Impact factor: 10.422

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Structure of full-length cDNA coding for sulfatide activator, a Co-beta-glucosidase and two other homologous proteins: two alternate forms of the sulfatide activator.

Authors:  T Nakano; K Sandhoff; J Stümper; H Christomanou; K Suzuki
Journal:  J Biochem       Date:  1989-02       Impact factor: 3.387

View more
  5 in total

1.  A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).

Authors:  D Wrobe; M Henseler; S Huettler; S I Pascual Pascual; A Chabas; K Sandhoff
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

2.  The exon 8-containing prosaposin gene splice variant is dispensable for mouse development, lysosomal function, and secretion.

Authors:  Tsadok Cohen; Wojtek Auerbach; Liat Ravid; Jacques Bodennec; Amos Fein; Anthony H Futerman; Alexandra L Joyner; Mia Horowitz
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  Cellular uptake of saposin (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor-related protein (LRP).

Authors:  T Hiesberger; S Hüttler; A Rohlmann; W Schneider; K Sandhoff; J Herz
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

4.  Developmental and tissue-specific expression of prosaposin mRNA in murine tissues.

Authors:  Y Sun; D P Witte; G A Grabowski
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

5.  A novel homozygous splicing mutation in PSAP gene causes metachromatic leukodystrophy in two Moroccan brothers.

Authors:  Laura Siri; Andrea Rossi; Federica Lanza; Raffaella Mazzotti; Anna Costa; Marina Stroppiano; Alberto Gaiero; Amnon Cohen; Roberta Biancheri; Mirella Filocamo
Journal:  Neurogenetics       Date:  2014-01-31       Impact factor: 2.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.